Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 3
2015 5
2016 3
2017 4
2018 1
2019 2
2020 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
Reid M, Agbassi YJP, Arinaminpathy N, Bercasio A, Bhargava A, Bhargava M, Bloom A, Cattamanchi A, Chaisson R, Chin D, Churchyard G, Cox H, Denkinger CM, Ditiu L, Dowdy D, Dybul M, Fauci A, Fedaku E, Gidado M, Harrington M, Hauser J, Heitkamp P, Herbert N, Herna Sari A, Hopewell P, Kendall E, Khan A, Kim A, Koek I, Kondratyuk S, Krishnan N, Ku CC, Lessem E, McConnell EV, Nahid P, Oliver M, Pai M, Raviglione M, Ryckman T, Schäferhoff M, Silva S, Small P, Stallworthy G, Temesgen Z, van Weezenbeek K, Vassall A, Velásquez GE, Venkatesan N, Yamey G, Zimmerman A, Jamison D, Swaminathan S, Goosby E. Reid M, et al. Among authors: lessem e. Lancet. 2023 Oct 21;402(10411):1473-1498. doi: 10.1016/S0140-6736(23)01379-X. Epub 2023 Sep 13. Lancet. 2023. PMID: 37716363 Review. No abstract available.
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?
Reuter A, Tisile P, von Delft D, Cox H, Cox V, Ditiu L, Garcia-Prats A, Koenig S, Lessem E, Nathavitharana R, Seddon JA, Stillo J, von Delft A, Furin J. Reuter A, et al. Among authors: lessem e. Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1114-1126. doi: 10.5588/ijtld.17.0468. Int J Tuberc Lung Dis. 2017. PMID: 29037291 Review.
Real engagement with communities.
Mingote LR, Vandevelde W, Kumar B, Lessem E. Mingote LR, et al. Among authors: lessem e. Lancet Respir Med. 2015 Jan;3(1):e2. doi: 10.1016/S2213-2600(14)70309-1. Lancet Respir Med. 2015. PMID: 25593092 No abstract available.
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.
Nachman S, Ahmed A, Amanullah F, Becerra MC, Botgros R, Brigden G, Browning R, Gardiner E, Hafner R, Hesseling A, How C, Jean-Philippe P, Lessem E, Makhene M, Mbelle N, Marais B, McIlleron H, McNeeley DF, Mendel C, Murray S, Navarro E, Anyalechi EG, Porcalla AR, Powell C, Powell M, Rigaud M, Rouzier V, Samson P, Schaaf HS, Shah S, Starke J, Swaminathan S, Wobudeya E, Worrell C. Nachman S, et al. Among authors: lessem e. Lancet Infect Dis. 2015 Jun;15(6):711-20. doi: 10.1016/S1473-3099(15)00007-9. Epub 2015 May 6. Lancet Infect Dis. 2015. PMID: 25957923 Free PMC article. Review.
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.
Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR Jr, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM. Dheda K, et al. Among authors: lessem e. Lancet Respir Med. 2017 Mar 15:S2213-2600(17)30079-6. doi: 10.1016/S2213-2600(17)30079-6. Online ahead of print. Lancet Respir Med. 2017. PMID: 28344011 Review.
Public investments in the clinical development of bedaquiline.
Gotham D, McKenna L, Frick M, Lessem E. Gotham D, et al. Among authors: lessem e. PLoS One. 2020 Sep 18;15(9):e0239118. doi: 10.1371/journal.pone.0239118. eCollection 2020. PLoS One. 2020. PMID: 32946474 Free PMC article.
Engaging communities in tuberculosis research.
Boulanger RF, Seidel S, Lessem E, Pyne-Mercier L, Williams SD, Mingote LR, Scott C, Chou AY, Lavery JV; Critical Path to TB Drug Regimens' Stakeholder and Community Engagement Workgroup. Boulanger RF, et al. Among authors: lessem e. Lancet Infect Dis. 2013 Jun;13(6):540-5. doi: 10.1016/S1473-3099(13)70042-2. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531390
Informed use of bedaquiline for tuberculosis.
Lessem EM, Bernardo J, Reed C, Wegener DH. Lessem EM, et al. Lancet. 2015 May 2;385(9979):1724. doi: 10.1016/S0140-6736(15)60885-6. Lancet. 2015. PMID: 25943933 No abstract available.
The evolving role of advocacy in tuberculosis.
DeLuca A, Lessem E, Wegener D, Mingote LR, Frick M, Von Delft D. DeLuca A, et al. Among authors: lessem e. Lancet Respir Med. 2014 Apr;2(4):258-9. doi: 10.1016/S2213-2600(14)70035-9. Epub 2014 Mar 24. Lancet Respir Med. 2014. PMID: 24717620 No abstract available.
25 results